Crosstalk of carcinoembryonic antigen and transforming growth factor-ß via their receptors: comparing human and canine cancer.
Cancer Immunol Immunother
; 64(5): 531-7, 2015 May.
Article
en En
| MEDLINE
| ID: mdl-25832000
ABSTRACT
There is accumulating evidence that the transforming growth factor beta (TGF-ß) and nuclear factor kappa-B (NFκB) pathways are tightly connected and play a key role in malignant transformation in cancer. Immune infiltration by regulatory T- and B-lymphocytes (Tregs, Bregs) has recently gained increased attention for being an important source of TGF-ß. There is a plethora of studies examining the pro-tumorigenic functions of carcinoembryonic antigen (CEA), but its receptor CEAR is far less studied. So far, there is a single connecting report that TGF-ß also may signal through CEAR. The crosstalk between cancer tissues is further complicated by the expression of CEAR and TGF-ß receptors in stromal cells, and implications of TGF-ß in epithelial-mesenchymal transition. Furthermore, tumor-infiltrating Tregs and Bregs may directly instruct cancer cells by secreting TGF-ß binding to their CEAR. Therefore, both TGF-ß and CEA may act synergistically in breast cancer and cause disease progression, and NFκB could be a common crossing point between their signaling. CEAR, TGF-ß1-3, TGF-ß-R types I-III and NFκB class I and II molecules have an outstanding human-canine sequence identity, and only a canine CEA homolog has not yet been identified. For these reasons, the dog may be a valid translational model patient for investigating the crosstalk of the interconnected CEA and TGF-ß networks.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Antígeno Carcinoembrionario
/
Factor de Crecimiento Transformador beta
/
Receptores de Factores de Crecimiento Transformadores beta
/
Receptores de Superficie Celular
/
Enfermedades de los Perros
/
Neoplasias
Tipo de estudio:
Prognostic_studies
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Cancer Immunol Immunother
Asunto de la revista:
ALERGIA E IMUNOLOGIA
/
NEOPLASIAS
/
TERAPEUTICA
Año:
2015
Tipo del documento:
Article